We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-13.92%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.18B
AUM Growth
-$341M
Cap. Flow
+$97.8M
Cap. Flow %
4.49%
Top 10 Hldgs %
35.92%
Holding
3,540
New
358
Increased
1,256
Reduced
1,110
Closed
245
Avg Time Held Equity + Options
3.1 years
Top 10 Avg Time Held Equity + Options
2.1 years
Top 20 Avg Time Held Equity + Options
2.3 years
Avg Time Held Equity only
3.1 years
Top 10 Avg Time Held Equity only
2.1 years
Top 20 Avg Time Held Equity only
2.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 52.29%
2 Technology 12.73%
3 Financials 8.79%
4 Healthcare 8.35%
5 Communication Services 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ISBC
3501
DELISTED
Investors Bancorp, Inc.
ISBC
– –
-820
Closed -$13K –
FLOW icon
3502
DELISTED
SPX FLOW, Inc.
FLOW
– –
-97
Closed -$8K –
PBCT
3503
DELISTED
People's United Financial Inc
PBCT
– –
-3,057
Closed -$62K –
VRS
3504
DELISTED
Verso Corporation
VRS
– –
-35
Closed -$1K –
ITMR
3505
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$0 ﹤0.01%
25
– –
2020 Q3
7 quarters
DSPG
3506
DELISTED
DSP Group Inc
DSPG
$0 ﹤0.01%
73
– –
2020 Q1
9 quarters
PVAL icon
3507
DELISTED
Principal Contrarian Value Index ETF
PVAL
– –
-100
Closed -$3K –
CTST
3508
DELISTED
CannTrust Holdings Inc. Common Share
CTST
– –
-100
Closed – –
WTRU
3509
DELISTED
Essential Utilities, Inc.6.00% Tangible Equity Units
WTRU
– –
-80
Closed -$5K –
MFGP
3510
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$0 ﹤0.01%
113
+1
+0.9% +$5
2017 Q3
19 quarters
NAVB
3511
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$0 ﹤0.01%
350
– –
2020 Q1
9 quarters
RHE
3512
DELISTED
Regional Health Properties, Inc.
RHE
$0 ﹤0.01%
+61
New +$168
2022 Q2
0 quarters
GTT
3513
DELISTED
GTT Communications, Inc.
GTT
$0 ﹤0.01%
60
– –
2021 Q2
4 quarters
CTIC
3514
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$0 ﹤0.01%
+29
New +$148
2022 Q2
0 quarters
EGLE icon
3515
DELISTED
Eagle Bulk Shipping Inc.
EGLE
– –
-14
Closed -$1K –
HIBB icon
3516
DELISTED
Hibbett, Inc. Common Stock
HIBB
$0 ﹤0.01%
3
-6
-67% -$277
2021 Q1
5 quarters
MBT
3517
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$0 ﹤0.01%
710
– –
2019 Q3
11 quarters
WBK
3518
DELISTED
Westpac Banking Corporation
WBK
$0 ﹤0.01%
411
– –
2016 Q4
22 quarters
AZPN icon
3519
DELISTED
ASPEN TECHNOLOGY INC
AZPN
– –
-293
Closed -$48K –

Similar funds

Parallel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Parallel Advisors held 3,540 positions worth $2.18B, down 14% from $2.52B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Parallel Advisors deployed $97.8M of net new capital in Q2 2022, opening 358 new positions and adding to 1,256 existing holdings. Its largest new stake was Dimensional US Marketwide Value ETF: 26,194 shares worth $828K.

By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 51% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares MSCI USA Value Factor ETF, an estimated $20.7M trimmed.

  • Parallel Advisors's largest Q2 2022 buy was Dimensional US Marketwide Value ETF: 26,194 shares worth $828K.
  • Parallel Advisors added most to Schwab US Dividend Equity ETF in Q2 2022, an estimated $39.1M increase.
  • Parallel Advisors's biggest Q2 2022 reduction was iShares MSCI USA Value Factor ETF, cutting an estimated $20.7M.
  • Parallel Advisors fully exited ZYNGA INC. CL A COMMON in Q2 2022, selling an estimated $7.79M.
  • Parallel Advisors's ten largest holdings make up 36% of its $2.18B portfolio in Q2 2022.
  • Parallel Advisors opened 358 new positions and closed 245 in Q2 2022.
  • Parallel Advisors's portfolio value fell 14% quarter-over-quarter to $2.18B.

Based on Parallel Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.